Personalis - Bathi operasional EBITDA PSNL
Personalis, Inc. (PSNL) generates revenue from high-precision genetic tests for personalized therapy and pharmaceutical development support. Business scalability is driven by DNA software analysis, which reduces research costs. Its status as a scientific innovator is confirmed by the trust of leading oncology centers. The EBITDA financial metric reflects the actual volume of cash inflows from operations, with the indicator remaining at 0.00.
Personalis (PSNL) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang Agregat marang Ekuitas Personalis, Inc.|PSNL - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Personalis Inc|PSNL - Utang perusahaan|Rasio utang marang aset resik Personalis|PSNL - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Personalis|Likuiditas darurat personalis.com
- statistik bathi lan rasio pasar:
PSNL - Bathi resik perusahaan|Prakiraan bathi resik Personalis, Inc.|PSNL - Pangali P/E|Pangali Forward P/E personalis.com|PSNL - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Personalis|PSNL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Personalis|PSNL - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan personalis.com|PSNL - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Personalis, Inc.
Analisis kabeh metrik perusahaan:Personalis Genomics
The development of NeXT Personal NGS testing by Personalis, Inc. (PSNL) requires significant R&D capital expenditures and partnerships with big pharma. This indicator measures the actual inflow of liquidity from operating activities, excluding the accounting lags of quarterly reporting. This allows investors to promptly detect the depletion of cash flows or their abnormal growth. Analysis of absolute operating profit reveals the real viability of the business model. The trend in absolute operating profit serves as a leading indicator of the company's financial health.
Pesaing Personalis, Inc. (PSNL)
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Erasca, Inc. (ERAS)|DCTH: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Aura Biosciences Inc (AURA) - Bathi sadurunge bunga, pajak, lan amortisasi|CADL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ARAY (Accuray, Inc.)|sellaslifesciences.com (SLS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ACTU - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Citius Oncology|Bathi sadurunge bunga, pajak, lan amortisasi TuHURA HURA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protara (TARA)|Fate Pharma - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA WHWK (Aadi Bioscience)|Bathi operasional EBITDA TScan Therapeutics Inc TCRX|CSBR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|XBIT: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CVM: Bathi operasional EBITDA|OSTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Radiopharm Theranostics|Artiva (ARTV) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi ANL (Adlai Nortye Ltd.)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TPST (Tempest Tx)|Pendapatan operasional sadurunge ngurangi amortisasi Xilio Therapeutics Inc (XLO)|RENB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MURA (Mural Oncology plc) - Bathi operasional sadurunge amortisasi|KAPA: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi OnKure Therapeutics|Bathi operasional sadurunge ngurangi amortisasi GDTC|Curis Corp (CRIS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Apollomics, Inc. (APLM)|THAR: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Advanced Biomed ADVB|Pendapatan operasional sadurunge ngurangi amortisasi Genprex Inc. (GNPX)|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SBFM (sunshinebiopharma.com) - Bathi operasional sadurunge amortisasi|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX (salariuspharma.com) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi AON (AONC)|Bathi operasional EBITDA BGNE|Bathi operasional EBITDA Checkpoint Therapeutics Inc (CKPT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD: Bathi operasional sadurunge amortisasi|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi MorphoSys Corporation (MOR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|AAPGV: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi
